CACNA1H
MOLECULAR TARGETcalcium voltage-gated channel subunit alpha1 H
CACNA1H (calcium voltage-gated channel subunit alpha1 H) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CACNA1H
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | oxatomide [Supplementary Concept] structure; | 1.39 | 3 |
| 2 | Ethosuximide | 0.69 | 1 |
| 3 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 4 | Calcimycin | 0.69 | 1 |
| 5 | Danazol | 0.69 | 1 |
| 6 | Estriol | 0.69 | 1 |
| 7 | Ezetimibe | 0.69 | 1 |
| 8 | Flunarizine Flunarizine is | 0.69 | 1 |
| 9 | Hexachlorophene | 0.69 | 1 |
| 10 | Loratadine | 0.69 | 1 |
| 11 | Metergoline | 0.69 | 1 |
| 12 | Nicardipine | 0.69 | 1 |
| 13 | Oxytetracycline | 0.69 | 1 |
| 14 | Ritonavir | 0.69 | 1 |
About CACNA1H as a Drug Target
CACNA1H (calcium voltage-gated channel subunit alpha1 H) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented CACNA1H interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CACNA1H inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.